⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9423718 | 0.84 | TDP1 (0.33) | — | |
| SCHEMBL1837883 | 0.83 | — | — | |
| SCHEMBL5512486 | 0.81 | GPR84 (0.39) | — | |
| SCHEMBL9423565 | 0.79 | EYA2 (0.30) | — | |
| SCHEMBL27690933 | 0.78 | — | — | |
| SCHEMBL11071506 | 0.77 | — | — | |
| SCHEMBL9423435 | 0.77 | LMNA (0.32) | — | |
| SCHEMBL22677556 | 0.77 | — | — | |
| SCHEMBL9423516 | 0.77 | LMNA (0.32) | — | |
| SCHEMBL29405783 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | disclosed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | disclosed |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2024-09-26 | — | — | US | disclosed |
| EP-4211146-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | Bar Ilan University (IL) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022054062-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2022-03-17 | — | — | WO | disclosed |
| US-20200268714-A1 | SPIROCYCLIC COMPOUNDS | KALYRA PHARMACEUTICALS, INC. | 2020-08-27 | — | — | US | disclosed |
| EP-3277690-B1 | SPIROCYCLIC COMPOUNDS | RECURIUM IP HOLDINGS LLC (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20190201380-A1 | SPIROCYCLIC COMPOUNDS | KALYRA PHARMACEUTICALS, INC. | 2019-07-04 | — | — | US | disclosed |
| US-20180207132-A1 | SPIROCYCLIC COMPOUNDS | RECURIUM IP HOLDINGS, LLC | 2018-07-26 | — | — | US | disclosed |
| EP-3277690-A1 | SPIROCYCLIC COMPOUNDS | Kalyra Pharmaceuticals, Inc. (US) | 2018-02-07 | — | — | EP | disclosed |
| WO-2016161160-A1 | SPIROCYCLIC COMPOUNDS | KALYRA PHARMACEUTICALS, INC. (US) | 2016-10-06 | — | — | WO | disclosed |
| EP-1799653-A2 | NOVEL HETEROCYCLES | Bayer Pharmaceuticals Corporation (US) | 2007-06-27 | — | — | EP | disclosed |
| WO-2006023843-A2 | NOVEL HETEROCYCLES | BAYER PHARMACEUTICALS CORPORATION (US) | 2006-03-02 | — | — | WO | disclosed |
| EP-0121850-B1 | PROCESS FOR PREPARING A CELLULAR POLYURETHANE | BAYER AG (DE) | 1989-08-30 | — | — | EP | disclosed |
| EP-0236895-A2 | Process for preparing a cellular polyurethane | BAYER AG (DE) | 1987-09-16 | — | — | EP | disclosed |
| EP-0121850-A2 | Process for preparing a cellular polyurethane | BAYER AG (DE) | 1984-10-17 | — | — | EP | disclosed |